In a Cell study, an experimental intranasal vaccine created by scientists at the Washington University School of Medicine has shown to bring about an immune response in the mucosa which prevents COVID-19 infection.
Researchers have since developed an intranasal biotechnology spray which makes it difficult for the virus to attach to human cells, and when used daily it is able to block transmission...
